Nicotine neuroprotection against nigrostriatal damage: importance of the animal model
- 31 May 2007
- journal article
- review article
- Published by Elsevier
- Vol. 28 (5) , 229-235
- https://doi.org/10.1016/j.tips.2007.03.001
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous SystemAnnual Review of Pharmacology and Toxicology, 2007
- Partial Recovery of Striatal Nicotinic Receptors in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Monkeys with Chronic Oral NicotineThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Nicotine partially protects against paraquat‐induced nigrostriatal damage in mice; link to α6β2* nAChRsJournal of Neurochemistry, 2006
- Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanismsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2006
- Diagnosis and treatment of Parkinson disease: molecules to medicineJournal of Clinical Investigation, 2006
- Chronic Oral Nicotine Normalizes Dopaminergic Function and Synaptic Plasticity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned PrimatesJournal of Neuroscience, 2006
- Desensitization of nicotinic ACh receptors: shaping cholinergic signalingPublished by Elsevier ,2005
- Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTPCell and tissue research, 2004
- Nicotine addiction: the possible role of functional upregulationTrends in Pharmacological Sciences, 2002
- Inhibition of monoamine oxidase B in the brains of smokersNature, 1996